Press Releases

Press Releases

October 26, 2021
Establishment Labs to Announce Third Quarter 2021 Financial Results on November 9
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Oct. 26, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the
October 14, 2021
Establishment Labs Launches JOY™
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Oct. 14, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the launch of JOY ™ , a new
September 30, 2021
Establishment Labs Announces Events for Pink October and Breast Cancer Awareness Month
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Sep. 30, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced the events and activities planned
September 2, 2021
Establishment Labs Launches Motiva Flora Tissue Expander in Europe and Other CE Mark Countries
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Sep. 2, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, held a symposium at the London Breast Meeting on
August 20, 2021
Establishment Labs to Launch Motiva Flora Tissue Expander at London Breast Meeting on September 2, 2021
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Aug. 20, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it will host an event on September
August 11, 2021
CORRECTING and REPLACING Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Aug. 11, 2021-- Presentation time in the release dated August 2, 2021 , should read 8:00 am PT on Thursday, August 12, 2021 (instead of 8 am ET ). The updated release reads: ESTABLISHMENT LABS ANNOUNCES PARTICIPATION IN THE UBS GENOMICS 2.0 AND MEDTECH
August 2, 2021
Establishment Labs Announces Participation in the UBS Genomics 2.0 and MedTech Innovations Summit
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Aug. 2, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Chief
July 29, 2021
Establishment Labs Reports Record Second Quarter 2021 Financial Results and Raises Full Year Guidance
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 29, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second
July 20, 2021
Establishment Labs Releases 2020 Corporate Social Responsibility Annual Review
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 20, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced publication of its 2020 Corporate Social Responsibility
July 16, 2021
Establishment Labs to Announce Second Quarter 2021 Financial Results on July 29
SANTA BARBARA, Calif. --(BUSINESS WIRE)--Jul. 16, 2021-- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2021
Displaying 1 - 10 of 30